Topol: Clinical trials offer exciting examples of convergence of digital health and drug development
One of the exciting and frustrating things about convergence, particularly in healthcare, is that it’s tough to predict how the hybrid technologies will find their way to market. The process of ...
While ideally the subjects of a clinical trial should reflect the diversity of the population that’s likely to use the drug, in practice this doesn’t always happen. Trials often under-enroll women, ...
This article presents an example of how clinical trial data may be complemented by real-world evidence by reviewing pivotal clinical trial data for one direct oral anticoagulant (DOAC), along with an ...
"The idea is that any provider all over the world potentially participates in a clinical trial," Oracle' Seema Verma said.
Background: Clinical trials do not represent community settings,making widespread implementation of evidence-based medicineproblematic. New heart failure treatments are an example, asresults ...
What’s the Difference Between Nontherapeutic and Therapeutic? Benefits of Nontherapeutic Clinical Trials Examples of Nontherapeutic Clinical Trials How to Find a Nontherapeutic Clinical Trial When you ...
The WELL Center at Drexel University provides state-of-the art, evidence-based treatment for weight management, eating disorders and related conditions. We seek participants for a wide range of ...
Artificial intelligence (AI) offers a new path forward for clinical trial sponsors, contract research organizations (CROs), and research sites collaborating on trials. By replacing reactive protocols ...
Integrating Patient-Reported Outcomes Into Cancer Symptom Management Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks The purpose of this article is to ...
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network The current dose-finding methodology ...
Please provide your email address to receive an email when new articles are posted on . Racial disparities in cancer clinical trial enrollment have existed for decades, with Black, Hispanic and other ...
Background: Double-blind placebo-controlled trials are intended to control for the impact of expectancy on outcomes. Whether they always achieve this is, however, questionable. Methods: Reanalysis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback